✦ LIBER ✦

Cost effectiveness of risk reduction: the managed care perspective

✍ Scribed by Mervin Shalowitz; Alan H. Heaton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNL9 COST-EFFECTIVENESS OFTOPIRAMATE FOR

✍ J Brown; M Rupnow; PJ Neumann; M Friedman; J Menzin 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Cost-Effectiveness of Rosuvastatin Compa

✍ Joshua S. Benner; Timothy W. Smith; David Klingman; Jonothan C. Tierce; C. Danie 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

PIN17 COST-EFFECTIVENESS MODELING OF TRE

✍ W Klaskala; FT Shaya; CD Mullins; AW Law; K Pettit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PND11 COMPARATIVE ANALYSIS OF MULTIPLE S

✍ D Papshev; R Bennett; A AL-Sabbagh 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PAO3: COST OF CARE FOR MEMBERS WITH ARTH

✍ M Schaffer; A Howe; S Mansukani 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

The cost-effectiveness of supportive per

✍ Mark Pennington; Peter Heasman; Francesca Gaunt; Arndt Güntsch; Saso Ivanovski; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB